SELECT * FROM `tbl_content` WHERE `c_type` = 'advertise' AND `c_status` = '1' AND `c_is_deleted` = '0' ORDER BY `c_order` desc LIMIT 3 Association of Biotechnology Led Enterprises


Dr Harsh Vardhan launches WHO India Country Cooperation Strategy 2019–2023

The Country Cooperation Strategy (CCS) provides a strategic roadmap for WHO to work with the Government of India towards achieving its health sector goals

Oct 10, 2019

By : Team ABLE

Biocon and Mylan launch Insulin Glargine biosimilar Semglee in Australia

Insulin glargine is a long-acting basal insulin analogue, given once daily to help control the blood sugar levels of those with diabetes.

Oct 03, 2019

By : Team ABLE

Viela Bio, Mitsubishi Tanabe to co-develop, commercialize autoimmune disease drug in Japan and nine Asia regions

Mitsubishi Tanabe will lead the development and commercialization of inebilizumab in Japan, Thailand, South Korea, Indonesia, Vietnam, Malaysia, Philippines, Singapore, and Taiwan.

Oct 09, 2019

By : By Team ABLE

18% GST on biotech research services removed

Bangalore, 21 September 2018: The government has removed the 18% GST ( goods and services tax) levied on research services provided to foreign companies by biotech companies based in India. This was a major un-competitive factor making Indian biotech services uncompetitive. ABLE has been championing the need for this exemption for the last 18 months.

Sep 21, 2019

By : Narayanan Suresh

ABLE suggests key changes in ICMR gene therapy guidelines

While welcoming the comprehensive Draft Guidelines for Gene Therapy Product Development and Clinical Trials announced by the Indian Council of Medical Research (ICMR), the Association of Biotechnology Led Enterprises(ABLE) has suggested some key changes to be incorporated in the final guidelines.

Sep 18, 2019

By : Team ABLE